# Farmalatam Holding

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/farmalatam-holding

- Industry: Internet
- Headquarters: Bogota, Colombia
- Website: www.farmalisto.com
- Total disclosed funding: $24M
- Latest round: Series B (Nov 28, 2022)
- Investors on record: 3

## About

Farmalatam Holding Inc. operates as an online pharmacy and healthcare product distributor, providing innovative solutions to address healthcare needs efficiently and effectively.Founded in 2013 and headquartered in Bogota, Colombia, Farmalatam Holding Inc. specializes in the distribution of healthcare products through its online platform, Farmalisto. The company has engaged in 12 deals since its inception, with its most recent funding round occurring on June 2, 2023, where it raised USD 2 million in VENTURE DEBT from HBM Partners, bringing its total funds raised to USD 2.58 mn. The current CEO is Christian Benavides, who leads the company towards its strategic goals.Farmalatam Holding Inc. offers a range of healthcare products that are designed to meet specific market challenges. Their solutions are aimed at streamlining processes and enhancing user experiences, catering to a diverse clientele that includes individuals and businesses across international markets such as North America, Europe, and Asia. The company emphasizes functionality and user satisfaction by delivering tools and services that improve operational efficiency.In 2023, Farmalatam Holding Inc. reported a revenue of USD 3,187,504.10 and an EBITDA of USD -3,055,225.80. Their revenue model focuses on direct-to-consumer sales and business-to-business transactions, allowing customers to engage through structured pricing plans for subscriptions and one-time purchases. This approach helps establish long-term relationships with clients through tailored offerings and support services.Farmalatam Holding Inc. plans to leverage the recent funding of USD 2 million to enhance its product offerings and expand into new markets. The company is designing new products aimed at improving healthcare access and expects to launch these innovations in the upcoming year. Additionally, Farmalatam is targeting expansion into additional markets in Latin America to broaden its reach and customer base.

## Funding rounds

- Series B, Nov 28, 2022, $2.6M — HBM Partners
- Series B, Apr 25, 2022, $3.7M — HBM Partners
- Series B, Dec 21, 2020, $18M — HBM Partners, Morgan Rio Capital Management, IDB Invest

## Investors

- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series B
- Morgan Rio Capital Management (https://capitalatlas.ai/funds/morgan-rio-capital-management) — Series B
- IDB Invest (https://capitalatlas.ai/funds/idb-invest) — Series B